Targeting PSMA by radioligands in non-prostate disease—current status and future perspectives

…, B Noto, N Avramovic, LS Grubert, S Huss… - European journal of …, 2018 - Springer
Background Prostate-specific membrane antigen (PSMA) is the up-and-coming target for
molecular imaging of prostate cancer. Despite its name, non-prostate-related PSMA expression …

Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury

…, M Vucur, N Gassler, S Huss, S Klussmann… - Gut, 2012 - gut.bmj.com
Objective Monocyte chemoattractant protein-1 (MCP-1, CCL2), the primary ligand for chemokine
receptor C–C chemokine receptor 2 (CCR2), is increased in livers of patients with non-…

[HTML][HTML] Allele-defined genome of the autopolyploid sugarcane Saccharum spontaneum L.

…, Z Chen, T Ma, H Liu, SR Dhungana, SE Huss… - Nature …, 2018 - nature.com
… officinarum and a wild relative, S. spontaneum, to obtain disease resistance and stress
tolerance traits of S. spontaneum while backcrossing to S. officinarum to recover high biomass …

Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA …

S Huss, H Pasternack, MA Ihle, S Merkelbach-Bruse… - Human pathology, 2017 - Elsevier
… All GIST cases were diagnosed by an experienced senior pathologist specialized in soft
tissue pathology (HUS, EW, or RB). Immunohistochemical stainings of CD34 (clone QBEnd10, …

Fueling open‐source drug discovery: 177 small‐molecule leads against tuberculosis

…, J Escribano, R González, S Lozano, S Huss… - …, 2013 - Wiley Online Library
… In conclusion, as part of GSK′s continued commitment to open innovation in neglected
disease research, we are now making the data from our phenotypic screen against tuberculosis …

Enterocutaneous fistula: are treatments improving?

JM Draus Jr, SA Huss, NJ Harty, WG Cheadle… - Surgery, 2006 - Elsevier
BACKGROUND: We studied the etiology, treatment, and outcome of enterocutaneous
fistulas in 106 patients to evaluate our current practice and the impact of newer therapies—…

Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer

…, G Walenda, HW Zimmermann, M Vucur, S Huss… - Gut, 2012 - gut.bmj.com
Background Hepatocellular carcinoma (HCC) is a typical inflammation-associated cancer,
but may also provoke antitumour immune responses whose significance and underlying …

Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis

…, O Govaere, HW Zimmermann, N Gassler, S Huss… - Hepatology, 2014 - journals.lww.com
Chronic liver injury promotes hepatic inflammation, representing a prerequisite for organ
fibrosis. We hypothesized a contribution of chemokine receptor CCR6 and its ligand, CCL20, …

On the design of hardware building blocks for modern lattice-based encryption schemes

…, T Feller, M Schneider, J Buchmann, S Huss - … and Embedded Systems …, 2012 - Springer
… $ ← S for a value of x that is being sampled uniformly at random from the set S. For sampling
Gaussian distributed integers, we apply the rejection sampling approach. This method is, …

[PDF][PDF] Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C‐C motif chemokine receptor 8 in mice

…, L Hammerich, D Storch, M Bartneck, S Huss… - …, 2012 - Wiley Online Library
Chemokines critically control the infiltration of immune cells upon liver injury, thereby promoting
hepatic inflammation and fibrosis. The chemokine receptor CCR8 can affect trafficking of …